0001628908-23-000072.txt : 20230605 0001628908-23-000072.hdr.sgml : 20230605 20230605162351 ACCESSION NUMBER: 0001628908-23-000072 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230601 FILED AS OF DATE: 20230605 DATE AS OF CHANGE: 20230605 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WILLIAMS FRANK J CENTRAL INDEX KEY: 0001204938 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37415 FILM NUMBER: 23992847 MAIL ADDRESS: STREET 1: 800 NORTH GLEBE ROAD, SUITE 500 CITY: ARLINGTON STATE: VA ZIP: 22203 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Evolent Health, Inc. CENTRAL INDEX KEY: 0001628908 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT SERVICES [8741] IRS NUMBER: 320454912 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 800 NORTH GLEBE RD, SUITE 500 CITY: ARLINGTON STATE: VA ZIP: 22203 BUSINESS PHONE: 571-389-6000 MAIL ADDRESS: STREET 1: 800 NORTH GLEBE RD, SUITE 500 CITY: ARLINGTON STATE: VA ZIP: 22203 4 1 wf-form4_168599661662369.xml FORM 4 X0407 4 2023-06-01 0 0001628908 Evolent Health, Inc. EVH 0001204938 WILLIAMS FRANK J C/O EVOLENT HEALTH, INC. 800 NORTH GLEBE ROAD, SUITE 500 ARLINGTON VA 22203 1 0 0 0 1 Class A Common Stock 2023-06-01 4 M 0 19060 6.87 A 838872 D Class A Common Stock 2023-06-01 4 M 0 90940 10.27 A 929812 D Class A Common Stock 2023-06-01 4 S 0 9091 29.27 D 920721 D Class A Common Stock 2023-06-01 4 S 0 9969 29.75 D 910752 D Class A Common Stock 2023-06-01 4 S 0 41914 29.26 D 868838 D Class A Common Stock 2023-06-01 4 S 0 49026 29.74 D 819812 D Class A Common Stock 66064 I See footnote Class A Common Option (right to buy) 6.87 2023-06-01 4 M 0 19060 0 D 2025-02-01 Class A Common Stock 19060.0 0 D Class A Common Option (right to buy) 10.27 2023-06-01 4 M 0 90940 0 D 2026-03-01 Class A Common Stock 90940.0 17250 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2022. Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.63 to $29.62, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.63 to $29.83, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.60 to $29.59, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.60 to $29.86, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Shares held of record by the Frank Williams Irrevocable Trust. Mr. Williams serves as the Trustee of the Frank Williams Irrevocable Trust. The Class A Common Stock Options exercised vested on February 1, 2019. The Class A Common Stock Options exercised vested on March 1, 2017, March 1, 2018, March 1, 2019, and March 1, 2020. /s/ Jonathan Weinberg, Attorney-in-fact 2023-06-05